The most recent Phase III data from a heart failure candidate may have been underwhelming, but a look at the broader pipeline suggests the long period of drought in innovation could soon give way to...
...at Mount Sinai researchers have described a new epigenetic modification -- dopamine attachment to histone H3... ...more dopamine modifications in the midbrain of rats undergoing cocaine withdrawal. Midbrain overexpression of an H3... ...kappa light polypeptide gene enhancer in B cells 1 (NF-kB) (NFKB1) (p105) (p50)
ILIAS Biologics Inc.
...of translational gene therapy at the rare disease research unit of Pfizer Inc. (NYSE:PFE). The H3... ...diagnose and treat patients with cancer or hereditary disorders.
Gilead Sciences Inc.
Adaptimmune Therapeutics plc
Asklepios BioPharmaceutical Inc.